When choosing niacinamide skin care during GLP-1 treatment, start with the concern you want to address: fine lines, uneven color or a diagnosed pigment condition. Read the trial behind the claim before assuming that a larger percentage on a serum bottle will give a better result.
An elasticity measurement is one particular outcome
The abstract reports improvements in fine lines and wrinkles, pigmented spots, red blotchiness, yellowing and elasticity measured by cutometry. It does not quantify the size of those changes in the abstract. [1]
A statistically significant result does not tell you how noticeable the change would be to you. The study also does not establish replacement of facial fat or a treatment for weight-loss-related facial hollows. Keep the stated skin measurements beside the claim rather than translating “elasticity” into a lifting promise.
The 4% melasma trial asked a different question
A 2011 Mexican split-face trial studied 27 women with melasma for eight weeks. One side received 4% niacinamide cream and the other 4% hydroquinone cream; sunscreen was part of the protocol. Good-to-excellent improvement was reported for 44% on niacinamide and 55% on hydroquinone. Instrumental color measurements did not differ significantly between sides. [2]
Those results do not establish that the treatments are interchangeable. A small study without a statistically significant difference does not prove equivalence. It also cannot tell you whether a different niacinamide serum would produce the same result. [2]
Hydroquinone was a study comparator, not a suggestion to add it yourself. In the United States, FDA states that hydroquinone-containing skin-lightening products are not approved for over-the-counter sale. Discuss pigment treatment with a qualified clinician. [3]
Match the study formula to the bottle
Neither of these studies directly compares 5% with 10% niacinamide. They cannot answer a claim that doubling the concentration doubles the benefit. A percentage comparison needs evidence on the concentrations being compared, with an appropriate treatment comparison and the same intended outcome.
On the package, record the product name, stated niacinamide percentage if provided, and directions. Check the full ingredient list, particularly if the formula contains other active skin-care ingredients. If a seller cites research, ask whether it tested the finished product or a different formula containing niacinamide.
Plan the introduction before the review date
AAD advises testing a new product on a quarter-sized area, such as the underside of the arm or elbow bend, twice daily for seven to ten days using the normal amount and contact time. If redness, itching or swelling develops, wash it off and stop using it. [4]
Keep the start date and the products already in your routine in a short note. If you introduce a moisturizer, acid exfoliant and niacinamide serum together, later changes will be harder to attribute. Follow the product directions and any clinician's instructions rather than copying a research schedule onto an unrelated bottle.
These older trials were not studies of GLP-1 users and provide no evidence that niacinamide prevents medication-associated facial changes. For a pigment-care discussion, read melasma and tinted sunscreen. For introduction steps, see testing new skin-care products.
Printed book
How to Keep Your Face on GLP-1
$12.95 + free shipping
Order Now30 day money back guarantee
This article provides general education, not a diagnosis or an individual treatment plan. Medication information refers to US sources. Discuss medication, nutrition and cosmetic treatment decisions with qualified clinicians.
Read next
Skin & researchAcne Moisturizers: Hydration and Water Loss Had Different Results→Skin careAcne Scars During GLP-1: Identify the Mark Before Treatment→Sources
- Niacinamide: A B vitamin that improves aging facial skin appearanceBissett and colleagues, Dermatologic Surgery, 2005; primary abstract↩ Back to text
- A Double-Blind, Randomized Clinical Trial of Niacinamide 4% versus Hydroquinone 4% in the Treatment of MelasmaNavarrete-Solís and colleagues, Dermatology Research and Practice, 2011↩ Back to text
- Skin Product SafetyUS Food and Drug Administration↩ Back to text
- How to test skin care productsAmerican Academy of Dermatology↩ Back to text

